CAMBRIDGE, MA, Rare disease company advancing novel, liver-directed treatments for diverse genetic disorders, today announced the successful completion of a Series B financing. Read More
BOSTON, MA, Clinical-stage medical device company developing a new treatment for depression and other psychiatric disorders, today announced a $14 million funding round. Read More
SANTA MONICA, CA, Platform that is transforming the way students manage their college futures, today announced that it has secured additional funding. Read More
MENLO PARK, CA, Privately held medical device company, announced today the closing of an $18.5 million Series B round of financing led by Venrock and Aisling Capital. Read More
